{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:53:59Z","timestamp":1790265239983,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cpcardiol.2024.102926","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T08:06:38Z","timestamp":1730880398000},"page":"102926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transforming pediatric heart failure: Efficacy of low-dose sacubitril\/valsartan"],"prefix":"10.1016","volume":"50","author":[{"given":"Hui","family":"Zha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejia","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quancheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2024.102926_bib0001","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MOP.0000000000000807","article-title":"Update on pediatric heart failure","volume":"31","author":"Del Castillo","year":"2019","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0002","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00246-017-1787-2","article-title":"Systematic literature review on the incidence and prevalence of heart failure in children and adolescents","volume":"39","author":"Shaddy","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0003","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOP.0000000000000624","article-title":"Initial presentation and management of pediatric heart failure","volume":"30","author":"Romer","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40272-021-00485-9","article-title":"Drug treatment of heart failure in children: gaps and opportunities","volume":"24","author":"Weisert","year":"2022","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10741-018-9757-1","article-title":"Practical guidance on the use of sacubitril\/valsartan for heart failure","volume":"24","author":"Sauer","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0006","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jchf.2020.06.020","article-title":"Sacubitril\/Valsartan: neprilysin inhibition 5 years after PARADIGM-HF","volume":"8","author":"Docherty","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0007","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-019-01181-2","article-title":"Sacubitril\/Valsartan: updates and clinical evidence for a disease-modifying approach","volume":"79","author":"Fabris","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753944718784536","article-title":"Sacubitril\/Valsartan in cardiovascular disease: evidence to date and place in therapy","volume":"12","author":"Yandrapalli","year":"2018","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0009","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1017\/S1047951118001014","article-title":"Sacubitril\/Valsartan: potential treatment for paediatric heart failure","volume":"28","author":"Das","year":"2018","journal-title":"Cardiol Young"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009816","article-title":"Baseline characteristics of pediatric patients with heart failure due to systemic left ventricular systolic dysfunction in the PANORAMA-HF trial","volume":"16","author":"Shaddy","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115829","article-title":"Development and validation of a sensitive and simple LC-MS\/MS method for simultaneous quantitation of valsartan, sacubitril and sacubitrilat in pediatric population","volume":"238","author":"Yang","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10741-018-9692-1","article-title":"Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy","volume":"23","author":"Rupp","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0013","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jtcvs.2021.04.073","article-title":"Pediatric heart transplantation: year in review","volume":"162","author":"Deshpande","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1274990","article-title":"Does sacubitril\/valsartan work in children with heart failure?-a pilot study","volume":"10","author":"Xu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fped.2018.00420","article-title":"Potential and limitations of atrial natriuretic peptide as biomarker in pediatric heart failure-a comparative review","volume":"6","author":"Gangnus","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0016","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.healun.2024.01.012","article-title":"Sacubitril-valsartan vs ACE\/ARB in pediatric heart failure: a retrospective cohort study","volume":"43","author":"Hale","year":"2024","journal-title":"J Heart Lung Transp"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0017","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/00498254.2015.1014944","article-title":"Disposition and metabolism of [(14)C] Sacubitril\/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects","volume":"46","author":"Flarakos","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0018","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.115.068536","article-title":"Sacubitril is selectively activated by Carboxylesterase 1 (CES1) in the liver and the activation is affected by CES1 genetic variation","volume":"44","author":"Shi","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0019","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2459\/JCM.0b013e32832401d6","article-title":"The use of B-type natriuretic peptide in paediatric patients: a review of literature","volume":"10","author":"Favilli","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccep.2018.11.001","article-title":"The many faces of heart failure","volume":"11","author":"Snipelisky","year":"2019","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.cpcardiol.2024.102926_bib0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/164_2016_77","article-title":"Sacubitril\/Valsartan (LCZ696) in heart failure","volume":"243","author":"Khder","year":"2017","journal-title":"Handb Exp Pharmacol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:51:08Z","timestamp":1732744268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624005619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0146280624005619"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102926","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming pediatric heart failure: Efficacy of low-dose sacubitril\/valsartan","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102926"}}